Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

Omly a matter of time before we get the news and stuff the shorters.

I have edited some posts for spamming on this thread.


Ian

I can't find the article mentioned. C'est La Vie.

Looking at buys and sells etc.. overviewing past info. Stuck my oar in and bought a few more. Also have a small holding of Stanelco (SEO) Looked at the latter's graph seems indecisive. The only problem I see is if both companies waste money on litigation. (Know any shares in companies dealing in company litigation ???)

Big fall today. dont think its a particularly big problem but does anyone know the reason?

See nematodes still at it then.

Take a look at the chart , heading towards 60p and will need a number of mega deals to turn this ship round.

DYOR , etc , etc

What does BPRG have to say. Surely they need to make a statement on this!!

spoke to GH this morning and he said it was the most active share on aim and therefore vulnerable to this, but fundementally nothing is wrong

Fundementally you may be correct , technically it looks knackered.

ssanebs I don`t have shares in this stock but I am interested. This sort of talk reminds me of wiggins, when I lost 80% of my pot (before I became wise)

As I don`t have shares or any opinion I can be detached. I have just had a look at the chart and I completely agree with Dil. The target looks to be 60p max and the OBV is quite severely down and escalating

Depends on your timeframe Snip (& Dil again!). You are taking a short term TA view, not a long term one. If you can give me the TA take on a five year view I will be glad to hear it. Given that the price was 25p in the middle of 2003 and it is 85p now, I would say the uptrend is intact regardless of whether the price hits 60p or 100p in a month's time.

I hold this as an investment (at 43p, 46p, and a lot more at 105p - average cost 73p) so the short term outlook isn't my concern. This is especially because my entire watchlist shows most smaller shares down 30% - 50% since February so it isn't a stock specific problem that I should get worried about.

I do trust that you and Dil are comfortably short for the interim :)

Cheers
Bones

no way will I be short bones. I`ve left those days behind me. Bones you are well within your comfort zone re BPRG but there are quite a few others who bought in at 100+. Anyway I`m not ramping or de-ramping or making any suggestions except to say that those who bailed out when it slipped through 100 could buy in on a bounce off 60 (ish) and therefore obtain more shares for the same money

Bones - I'm a contrarian. Been watching BPRG for some time, done me own research and asked around especially in US.

Probably got me timing all wrong (usually do) but when everyone says buy on the Boards that's when I look to sell and vice versa.

The following is from today's Mail.
Down from 147 3/4p in early March, Aim-quoted drugs equipment developer Bioprogress lost 10 3/4p more to 88 1/4p. The company is said to be 'at a complete loss' as to the reason for the sharp fall. An LSE statement could be on the way.

Snip - all valid points of course!

Gianni - very fair approach. My original stake was bought last August but I bought my extras at 105p in March this year after the rapid decline to that level and the subsequent bounce. I am disappointed (short term) that the 100p level did not ultimately hold but I think this is due to a technically weak market as a whole, not a company-specific reason (but not helped by the rabid speculation of imminent deals that will one day be announced!). This company is not blue-sky. It doesn't need trials, it has blue chip pharmas after its technology and its factories are gearing up.

Given yesterday's monster volume of over 9m shares, that suggested a degree of capitulation after the 100p broke. If so, that is a good thing as it cools down the shareholder base and lessens the volatility in the long run. That will start again when the big deals are announced.....:)

I think the shorters are out in strength on BPRG; not the time to be selling!
I am taking a long term view on these - at least two years. I am just not clever enough to catch all the ups and downs and am taking a chunky loss at the moment. But I don't have to sell so I'll sit tight and watch the roller-coaster.

I think the shorters are out in strength on BPRG; not the time to be selling!
I am taking a long term view on these - at least two years. I am just not clever enough to catch all the ups and downs and am taking a chunky loss at the moment. But I don't have to sell so I'll sit tight and watch the roller-coaster.

Bones , no offence I know what it feels like ... I still got a shedload of Energis but the writing was on the wall from Feb time. Think how many more you could be holding now if you had acted upon those signs , this isn't a pullback its a nosedive.

In hindsight this is true Dil, and to an extent I did do that. I sold some at 157, 139 and 114 (in reverse on the way up) but I more than refilled at 105 (after it came down) - admittedly with a small snifter at 146p (about 10% of the holding). I am content with my holding for the long ride now (it is in a SIPP) and am not prepared to be out when they fly up which could always happen on any given day. I am happy to have my shedload at the average cost I have. Appreciate the advice though but happy to be oblivious to the real world!

Bones

PS Good luck with EGS - have you tightened your stop yet?

Dil you plonker,this is not energis...don't make silly comparisons.This will be the next microsoft!!!!!!!!!!

and here`s me thinking there were sensible discussions on this bb and post 511 has just decimated the high standard of the previous posts. And who is calling who a plonker? Don`t you realise nematode that you should never use the word `if` or `might` in other words `guesswork` but then again they are words used by the un-educated when it comes to stock decisions